Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample.

Bhatt P, Bray L, Raju S, Dapaah-Siakwan F, Patel A, Chaudhari R, Donda K, Bhatt NS, Dave M, Linga VG, Lekshminarayanan A, Patel SV, Billimoria ZC, Zuckerman S, Yagnik P, Singh D.

J Pediatr. 2018 Dec 6. pii: S0022-3476(18)31551-8. doi: 10.1016/j.jpeds.2018.10.044. [Epub ahead of print]

PMID:
30528761
2.

National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.

Lekshminarayanan A, Bhatt P, Linga VG, Chaudhari R, Zhu B, Dave M, Donda K, Savani S, Patel SV, Billimoria ZC, Bhaskaran S, Zaid-Kaylani S, Dapaah-Siakwan F, Bhatt NS.

J Pediatr. 2018 Nov;202:231-237.e3. doi: 10.1016/j.jpeds.2018.06.056. Epub 2018 Jul 17.

PMID:
30029861
3.

Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia.

Bhatt NS, Bhatt P, Donda K, Dapaah-Siakwan F, Chaudhari R, Linga VG, Patel B, Lekshminarayanan A, Bhaskaran S, Zaid-Kaylani S, Badawy SM.

Pediatr Blood Cancer. 2018 Jul;65(7):e27072. doi: 10.1002/pbc.27072. Epub 2018 Apr 10.

PMID:
29637697
4.

Renal Lymphoma: Primary or First Manifestation of Aggressive Pediatric B-cell Lymphoma.

Coca P, Linga VG, Gundeti S, Tandon A.

Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):538-541. doi: 10.4103/ijmpo.ijmpo_48_16.

5.

Effectiveness of Three Prognostic Scoring Systems in Predicting the Response and Outcome in Pediatric Chronic Myeloid Leukemia Chronic Phase on Frontline Imatinib.

Ganta RR, Nasaka S, Linga VG, Gundeti S, Maddali LS, Digumarti RR.

Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):282-286. doi: 10.4103/ijmpo.ijmpo_104_16.

6.

Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world.

Kumar KA, Sadashivudu G, Krishnamani KV, Linga VG, Maddali LS, Digumarti RR.

Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):260-264. doi: 10.4103/0971-5851.195738.

7.

Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy.

Bala S, Gundeti S, Linga VG, Maddali LS, Digumarti RR, Uppin SG.

Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):242-250. doi: 10.4103/0971-5851.195735.

8.

Impact of treatment protocol on outcome of localized Ewing's sarcoma.

Nasaka S, Gundeti S, Ganta RR, Arigela RS, Linga VG, Maddali LS.

South Asian J Cancer. 2016 Oct-Dec;5(4):194-195. doi: 10.4103/2278-330X.195344.

9.

Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia.

Arigela RS, Gundeti S, Ganta RR, Nasaka S, Linga VG, Maddali LS.

Indian J Med Paediatr Oncol. 2016 Jan-Mar;37(1):32-7. doi: 10.4103/0971-5851.177013.

10.

Bortezomib in newly diagnosed patients with multiple myeloma: A retrospective analysis from a tertiary care center in India.

Pragnya C, Linga VG, Thota NK, Gundeti S, Digumarti R.

Indian J Cancer. 2015 Oct-Dec;52(4):537-40. doi: 10.4103/0019-509X.178388.

11.

Clinical profile and outcome of adult Hodgkin lymphoma: Experience from a tertiary care institution.

Maddi RN, Linga VG, Iyer KK, Chowdary JS, Gundeti S, Digumarti R, Paul TR.

Indian J Med Paediatr Oncol. 2015 Oct-Dec;36(4):255-60. doi: 10.4103/0971-5851.171550.

12.

Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients.

Kota R, Gundeti S, Gullipalli M, Linga VG, Maddali LS, Digumarti R.

Lung India. 2015 Nov-Dec;32(6):561-5. doi: 10.4103/0970-2113.168099.

13.

Current profile of hepatocellular carcinoma from a tertiary care center in Andhra Pradesh.

Srirambhatla J, Linga VG, Kalpathi KM, Chowdary JS, Gundeti S, Digumarti R, Paul TR.

Indian J Gastroenterol. 2015 Jul;34(4):335-6. doi: 10.1007/s12664-015-0590-3. No abstract available.

PMID:
26394852
14.

The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis.

Yang CH, Pfeffer SR, Sims M, Yue J, Wang Y, Linga VG, Paulus E, Davidoff AM, Pfeffer LM.

J Biol Chem. 2015 Mar 6;290(10):6037-46. doi: 10.1074/jbc.M114.632125. Epub 2015 Jan 14.

15.

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia.

Linga VG, Patchva DB, Mallavarapu KM, Tulasi V, Kalpathi KI, Pillai A, Gundeti S, Rajappa SJ, Digumarti R.

Indian J Med Paediatr Oncol. 2014 Oct;35(4):276-80. doi: 10.4103/0971-5851.144989.

16.

Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase.

Linga VG, Ganta RR, Kalpathi KI, Gundeti S, Rajappa SJ, Digumarti R, Paul TR, Tandon A.

South Asian J Cancer. 2014 Oct;3(4):203-5. doi: 10.4103/2278-330X.142961.

17.

Primary intramedullary non-Hodgkin's lymphoma in an immunocompetent child.

Bhushanam TV, Rajesh A, Linga VG, Uppin MS, Malik M.

Spinal Cord. 2014 Aug;52 Suppl 2:S21-3. doi: 10.1038/sc.2014.96.

PMID:
25082378
18.

Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: a retrospective analysis.

Thota NK, Gundeti S, Linga VG, Coca P, Tara RP; Raghunadharao.

Indian J Cancer. 2014 Jan-Mar;51(1):5-9. doi: 10.4103/0019-509X.134598.

19.

Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India.

Kagita S, Uppalapati S, Jiwatani S, Linga VG, Gundeti S, Nagesh N, Digumarti R.

Tumour Biol. 2014 Jul;35(7):7187-93. doi: 10.1007/s13277-014-1926-9. Epub 2014 Apr 26.

PMID:
24763825
20.

Primary pleuropulmonary synovial sarcoma: A report of two cases and review of literature.

Kalpathi K, Linga VG, Digumarti R, Gundeti S, Uppin S.

South Asian J Cancer. 2013 Oct;2(4):231. doi: 10.4103/2278-330X.119933. No abstract available.

21.

Early molecular response in chronic myeloid leukemia patients predicts future response status.

Kagita S, Jiwtani S, Uppalapati S, Linga VG, Gundeti S, Digumarti R.

Tumour Biol. 2014 May;35(5):4443-6. doi: 10.1007/s13277-013-1585-2. Epub 2014 Jan 12.

PMID:
24414484
22.
23.

Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL.

Dorababu P, Naushad SM, Linga VG, Gundeti S, Nagesh N, Kutala VK, Reddanna P, Digumarti R.

Pharmacogenomics. 2012 Jul;13(9):1001-8. doi: 10.2217/pgs.12.70.

PMID:
22838948
24.

Is rituximab approved in pediatric non Hodgkin lymphoma?

Linga VG, Digumati R.

Indian Pediatr. 2012 May;49(5):419-20. No abstract available.

25.

Multiple myeloma presenting with hepatosplenomegaly.

Mallavarapu KM, Rajappa S, Linga VG, Gundeti S, Digumarthi R, Uppin SG.

J Assoc Physicians India. 2011 Jul;59:456-8.

PMID:
22315756
26.

Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.

Dorababu P, Nagesh N, Linga VG, Gundeti S, Kutala VK, Reddanna P, Digumarti R.

Eur J Clin Pharmacol. 2012 Apr;68(4):379-87. doi: 10.1007/s00228-011-1133-1. Epub 2011 Oct 19.

PMID:
22009189

Supplemental Content

Loading ...
Support Center